MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a representative neurodegenerative disorder characterized by the deposition of amyloid beta (Aβ) and tau proteins, leading to impairment of cognitive function and the ability to perform daily activities (Scheltens et al., 2016).